Published in
Wiley, British Journal of Haematology, 5(175), p. 917-924, 2016
DOI: 10.1111/bjh.14345
Links
Tools
Mammalian-target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes (MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D-MDS)
Journal article published in 2016 by
Martin Wermke,
Claudia Schuster,
Florian Nolte,
Haifa-Kathrin Al-Ali 
,
Philipp Kiewe,
Claudia Schönefeldt,
Christiane Jakob,
Malte von Bonin,
Leopold Hentschel,
Ina-Maria Klut,
Gerhard Ehninger,
Martin Bornhäuser,
Gustavo Baretton,
Ulrich Germing,
Regina Herbst
and other authors.
,
Philipp Kiewe,
Claudia Schönefeldt,
Christiane Jakob,
Malte von Bonin,
Leopold Hentschel,
Ina-Maria Klut,
Gerhard Ehninger,
Martin Bornhäuser,
Gustavo Baretton,
Ulrich Germing,
Regina Herbst
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 